The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
The role of the complement system in cancer
Open accessAbstract
In addition to being a component of innate immunity and an ancient defense mechanism against invading pathogens, complement activation also participates in the adaptive immune response, inflammation, hemostasis, embryogenesis, and organ repair and development. Activation of the complement system via classical, lectin, or alternative pathways generates anaphylatoxins (C3a and C5a) and membrane attack complex (C5b-9) and opsonizes targeted cells. Complement activation end products and their receptors mediate cell-cell interactions that regulate several biological functions in the extravascular tissue. Signaling of anaphylatoxin receptors or assembly of membrane attack complex promotes cell dedifferentiation, proliferation, and migration in addition to reducing apoptosis. As a result, complement activation in the tumor microenvironment enhances tumor growth and increases metastasis. In this Review, I discuss immune and nonimmune functions of complement proteins and the tumor-promoting effect of complement activation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Bialas, A. R., & Stevens, B. (2013) · Nature Neuroscience · doi:10.1038/nn.3560 · Cited by 519
RetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089
Complement: a key system for immune surveillance and homeostasis
Ricklin, D., Hajishengallis, G., Yang, K., & Lambris, J. D. (2010) · Nature Immunology · doi:10.1038/ni.1923 · Cited by 3,654 · cited 2×
“The complement system’s ability to distinguish self from non-self makes it an important part of the innate immune response to invading pathogens (46).”
BackgroundThe Classical Complement Cascade Mediates CNS Synapse Elimination
Stevens, B., Allen, N. J., Vazquez, L. E., Howell, G. R., Christopherson, K. S., Nouri, N., Micheva, K. D., Mehalow, A. K., Huberman, A. D., Stafford, B., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.036 · Cited by 3,313
Walport, M. J. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441406 · Cited by 2,927
Schizophrenia risk from complex variation of complement component 4
Sekar, A., Bialas, A. R., de Rivera, H., Davis, A., Hammond, T. R., Kamitaki, N., Tooley, K., Presumey, J., Baum, M., Van Doren, V., et al. (2016) · Nature · doi:10.1038/nature16549 · Cited by 2,394
Complement and its role in innate and adaptive immune responses
Dunkelberger, J. R., & Song, W.-C. (2010) · Cell Research · doi:10.1038/cr.2009.139 · Cited by 1,932
Walport, M. J. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104123441506 · Cited by 1,481
Complement regulators and inhibitory proteins
Zipfel, P. F., & Skerka, C. (2009) · Nature Reviews Immunology · doi:10.1038/nri2620 · Cited by 1,264
Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet?
Coussens, L. M., Zitvogel, L., & Palucka, A. K. (2013) · Science · doi:10.1126/science.1232227 · Cited by 1,079
Lovisa, S., LeBleu, V. S., Tampe, B., Sugimoto, H., Vadnagara, K., Carstens, J. L., Wu, C.-C., Hagos, Y., Burckhardt, B. C., Pentcheva-Hoang, T., et al. (2015) · Nature Medicine · doi:10.1038/nm.3902 · Cited by 978
Kusmartsev, S., Nefedova, Y., Yoder, D., & Gabrilovich, D. I. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.2.989 · Cited by 850
Modulation of the antitumor immune response by complement
Markiewski, M. M., DeAngelis, R. A., Benencia, F., Ricklin-Lichtsteiner, S. K., Koutoulaki, A., Gerard, C., Coukos, G., & Lambris, J. D. (2008) · Nature Immunology · doi:10.1038/ni.1655 · Cited by 778
The Role of Complement in Inflammatory Diseases From Behind the Scenes into the Spotlight
Markiewski, M. M., & Lambris, J. D. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070166 · Cited by 722
The role of mannose-binding lectin in health and disease
Turner, M. W. (2003) · Molecular Immunology · doi:10.1016/s0161-5890(03)00155-x · Cited by 634
Myeloid-derived suppressor cell heterogeneity and subset definition
Peranzoni, E., Zilio, S., Marigo, I., Dolcetti, L., Zanovello, P., Mandruzzato, S., & Bronte, V. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.01.021 · Cited by 630
Strainic, M. G., Liu, J., Huang, D., An, F., Lalli, P. N., Muqim, N., Shapiro, V. S., Dubyak, G. R., Heeger, P. S., & Medof, M. E. (2008) · Immunity · doi:10.1016/j.immuni.2008.02.001 · Cited by 580
Complement Activation Determines the Therapeutic Activity of Rituximab In Vivo
Di Gaetano, N., Cittera, E., Nota, R., Vecchi, A., Grieco, V., Scanziani, E., Botto, M., Introna, M., & Golay, J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.3.1581 · Cited by 576
Local synthesis of complement component C3 regulates acute renal transplant rejection
Pratt, J. R., Basheer, S. A., & Sacks, S. H. (2002) · Nature Medicine · doi:10.1038/nm0602-582 · Cited by 534
Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies
on behalf of the French Study Group for aHUS/C3G, Zuber, J., Fakhouri, F., Roumenina, L. T., Loirat, C., & Frémeaux-Bacchi, V. (2012) · Nature Reviews Nephrology · doi:10.1038/nrneph.2012.214 · Cited by 496
Complement in Immune and Inflammatory Disorders: Pathophysiological Mechanisms
Ricklin, D., & Lambris, J. D. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203487 · Cited by 478
The proinflammatory mediators C3a and C5a are essential for liver regeneration
Strey, C. W., Markiewski, M., Mastellos, D., Tudoran, R., Spruce, L. A., Greenbaum, L. E., & Lambris, J. D. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030374 · Cited by 436
Complement and Its Receptors: New Insights into Human Disease
Holers, V. M. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120154 · Cited by 430
PTX3 Is an Extrinsic Oncosuppressor Regulating Complement-Dependent Inflammation in Cancer
Bonavita, E., Gentile, S., Rubino, M., Maina, V., Papait, R., Kunderfranco, P., Greco, C., Feruglio, F., Molgora, M., Laface, I., et al. (2015) · Cell · doi:10.1016/j.cell.2015.01.004 · Cited by 417
Fishelson, Z. (2003) · Molecular Immunology · doi:10.1016/s0161-5890(03)00112-3 · Cited by 400
Regulation of Humoral Immunity by Complement
Carroll, M. C., & Isenman, D. E. (2012) · Immunity · doi:10.1016/j.immuni.2012.08.002 · Cited by 387
Complement activation and inhibition: a delicate balance
Sjöberg, A. P., Trouw, L. A., & Blom, A. M. (2009) · Trends in Immunology · doi:10.1016/j.it.2008.11.003 · Cited by 364
T-cell regulation: with complements from innate immunity
Kemper, C., & Atkinson, J. P. (2007) · Nature Reviews Immunology · doi:10.1038/nri1994 · Cited by 340
Mannose‐binding lectin: targeting the microbial world for complement attack and opsonophagocytosis
Jack, D. L., Klein, N. J., & Turner, M. W. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1800108.x · Cited by 336
Membrane attack by complement: the assembly and biology of terminal complement complexes
Tegla, C. A., Cudrici, C., Patel, S., Trippe, R., Rus, V., Niculescu, F., & Rus, H. (2011) · Immunologic Research · doi:10.1007/s12026-011-8239-5 · Cited by 321
Complement Fragment C3a Controls Mutual Cell Attraction during Collective Cell Migration
Carmona-Fontaine, C., Theveneau, E., Tzekou, A., Tada, M., Woods, M., Page, K. M., Parsons, M., Lambris, J. D., & Mayor, R. (2011) · Developmental Cell · doi:10.1016/j.devcel.2011.10.012 · Cited by 317
Evolution of enzyme cascades from embryonic development to blood coagulation
Krem, M. M., & Cera, E. D. (2002) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(01)02007-2 · Cited by 313
Connolly, D. C., Bao, R., Nikitin, A. Y., Stephens, K. C., Poole, T. W., Xiang, H., Harris, S. S., Vanderhyden, B. C., & Hamilton, T. C. (2003) · PubMed · Cited by 310
Bulla, R., Tripodo, C., Rami, D., Ling, G. S., Agostinis, C., Guarnotta, C., Zorzet, S., Durigutto, P., Botto, M., & Tedesco, F. (2016) · Nature Communications · doi:10.1038/ncomms10346 · Cited by 294
Anaphylatoxin C5a Creates a Favorable Microenvironment for Lung Cancer Progression
Corrales, L., Ajona, D., Rafail, S., Lasarte, J. J., Riezu-Boj, J. I., Lambris, J. D., Rouzaut, A., Pajares, M. J., Montuenga, L. M., & Pio, R. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201654 · Cited by 281
Lalli, P. N., Strainic, M. G., Yang, M., Lin, F., Medof, M. E., & Heeger, P. S. (2008) · Blood · doi:10.1182/blood-2008-04-151068 · Cited by 271
Inflammation and immune surveillance in cancer
Chow, M. T., Möller, A., & Smyth, M. J. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.12.004 · Cited by 241
Reca, R., Mastellos, D., Majka, M., Marquez, L., Ratajczak, J., Franchini, S., Glodek, A., Honczarenko, M., Spruce, L. A., Janowska-Wieczorek, A., et al. (2003) · Blood · doi:10.1182/blood-2002-10-3233 · Cited by 220
Pedersen, I. M., Buhl, A. M., Klausen, P., Geisler, C. H., & Jurlander, J. (2002) · Blood · doi:10.1182/blood.v99.4.1314 · Cited by 219
Autocrine Effects of Tumor-Derived Complement
Cho, M. S., Vasquez, H. G., Rupaimoole, R., Pradeep, S., Wu, S., Zand, B., Han, H.-D., Rodriguez-Aguayo, C., Bottsford-Miller, J., Huang, J., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.02.014 · Cited by 219
Self-citationImmune evasion of tumor cells using membrane-bound complement regulatory proteins
Gorter, A., & Meri, S. (1999) · Immunology Today · doi:10.1016/s0167-5699(99)01537-6 · Cited by 206
Wang, S.-Y., Racila, E., Taylor, R. P., & Weiner, G. J. (2008) · Blood · doi:10.1182/blood-2007-02-074716 · Cited by 194
Carboxypeptidase N: a pleiotropic regulator of inflammation
Matthews, K. W., Mueller-Ortiz, S. L., & Wetsel, R. A. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2003.10.002 · Cited by 185
Complement: more than a ‘guard’ against invading pathogens?
Mastellos, D. C., & Lambris, J. D. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02287-1 · Cited by 177
Peng, Q., Li, K., Anderson, K., Farrar, C. A., Lu, B., Smith, R. A. G., Sacks, S. H., & Zhou, W. (2008) · Blood · doi:10.1182/blood-2007-06-095018 · Cited by 173
Wang, Y., Sun, S.-N., Liu, Q., Yu, Y.-Y., Guo, J., Wang, K., Xing, B.-C., Zheng, Q.-F., Campa, M. J., Patz, E. F., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-1412 · Cited by 159
Complement inhibition in cancer therapy
Pío, R., Ajona, D., & Lambris, J. D. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.04.001 · Cited by 146
Persistent complement activation on tumor cells in breast cancer.
Niculescu, F. I., Rus, H., Retegan, M., et al. (1992) · PubMed · Cited by 144
Wang, S., Veeramani, S., Racila, E. V., Cagley, J. R., Fritzinger, D. C., Vogel, C.-W., John, W. S., & Weiner, G. J. (2009) · Blood · doi:10.1182/blood-2009-01-200469 · Cited by 143
Prang, N. S., Preithner, S., Brischwein, K., Göster, P., Wöppel, A., Müller, J., Steiger, C., Peters, M. J., Baeuerle, P. A., & da Silva, A. J. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602310 · Cited by 143
Nuñez-Cruz, S., Gimotty, P. A., Guerra, M. W., Connolly, D. C., Wu, Y., DeAngelis, R. A., Lambris, J. D., Coukos, G., & Scholler, N. (2012) · Neoplasia · doi:10.1593/neo.121262 · Cited by 142
Nabizadeh, J., Manthey, H. D., Steyn, F. J., Chen, W., Widiapradja, A., Akhir, F. N. M., Boyle, G. M., Taylor, S. M., Woodruff, T. M., & Rolfe, B. E. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600210 · Cited by 141
Is complement good or bad for cancer patients? A new perspective on an old dilemma
Markiewski, M. M., & Lambris, J. D. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.04.002 · Cited by 139
Donin, N., Jurianz, K., Ziporen, L., Schultz, S., Kirschfink, M., & Fishelson, Z. (2003) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2003.02066.x · Cited by 139
Ascitic complement system in ovarian cancer
Bjørge, L., Hakulinen, J., Vintermyr, O., Jarva, H., Jensen, T. S., Iversen, O. E., & Meri, S. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602334 · Cited by 133
C5a delays apoptosis of human neutrophils by a phosphatidylinositol 3-kinase-signaling pathway
Perianayagam, M. C., Balakrishnan, V. S., King, A. J., Pereira, B. J. G., & Jaber, B. L. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00139.x · Cited by 123
Ward, P. A. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0442-7 · Cited by 123
The complement system in cancer: Ambivalence between tumour destruction and promotion
Mamidi, S., Höne, S., & Kirschfink, M. (2015) · Immunobiology · doi:10.1016/j.imbio.2015.11.008 · Cited by 123
Soane, L., Cho, H.-J., Niculescu, F. I., Rus, H., & Shin, M. L. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.4.2305 · Cited by 122
Sublytic C5b-9 induces proliferation of human aortic smooth muscle cells
Niculescu, F. I., Badea, T. C., & Rus, H. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(98)00185-3 · Cited by 112
Expression of the Third Component of Complement, C3, in Regenerating Limb Blastema Cells of Urodeles
Rio‐Tsonis, K. D., Tsonis, P. A., Zarkadis, I. K., Tsagas, A. G., & Lambris, J. D. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.12.6819 · Cited by 105
Complement Factor H: A Biomarker for Progression of Cutaneous Squamous Cell Carcinoma
Riihilä, P., Nissinen, L. M., Ala‐aho, R., Kallajoki, M. A., Grenman, R. A., Meri, S., Peltonen, S. A., Peltonen, J. T. K., & Kähäri, V. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.346 · Cited by 103
Complement Component 3 Is Regulated by TWIST1 and Mediates Epithelial–Mesenchymal Transition
Cho, M. S., Rupaimoole, R., Choi, H. J., Noh, K., Chen, J., Hu, Q., Sood, A. K., & Afshar‐Kharghan, V. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1501886 · Cited by 101
Self-citationNitta, H., Wada, Y., Kawano, Y., Murakami, Y., Irie, A., Taniguchi, K., Kikuchi, K., Yamada, G., Suzuki, K., Honda, J., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1204 · Cited by 99
Taylor, R. P., & Lindorfer, M. A. (2016) · Seminars in Immunology · doi:10.1016/j.smim.2016.03.003 · Cited by 98
Increased Serum Levels of Complement C3a Anaphylatoxin Indicate the Presence of Colorectal Tumors
Habermann, J. K., Roblick, U. J., Luke, B. T., Prieto, D. A., Finlay, W. J. J., Podust, V. N., Roman, J. M., Oevermann, E., Schiedeck, T. H. K., Homann, N., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.07.011 · Cited by 97
Myeloid-derived suppressor cells in transplantation and cancer
Ochando, J., & Chen, S. (2012) · Immunologic Research · doi:10.1007/s12026-012-8335-1 · Cited by 94
Human CD59 Inhibitor Sensitizes Rituximab-Resistant Lymphoma Cells to Complement-Mediated Cytolysis
Hu, W., Ge, X., You, T., Xu, T., Zhang, J., Wu, G., Peng, Z., Chorev, M., Aktas, B. H., Halperin, J. A., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3016 · Cited by 91
Complement fragments C3a and C5a: The salt and pepper of the immune response
Sacks, S. H. (2010) · European Journal of Immunology · doi:10.1002/eji.201040355 · Cited by 89
Gancz, D., & Fishelson, Z. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.05.009 · Cited by 87
Complement Factor H as a Marker for Detection of Bladder Cancer
Cheng, Z.-Z., Corey, M. J., Pärepalo, M., Majno, S., Hellwage, J., Zipfel, P. F., Kinders, R. J., Raitanen, M., Meri, S., & Jokiranta, T. S. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2004.042192 · Cited by 83
Rituximab inhibits B-cell receptor signaling
Kheirallah, S., Caron, P., Gross, E. T. E., Quillet‐Mary, A., Bertrand‐Michel, J., Fournié, J., Laurent, G., & Bezombes, C. (2009) · Blood · doi:10.1182/blood-2009-08-237537 · Cited by 82
Chen (2009) · Oncology Reports · doi:10.3892/or_00000368 · Cited by 69
Raedler, H., Yang, M., Lalli, P. N., Medof, M. E., & Heeger, P. S. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02723.x · Cited by 66
van der Vlis, T. A. M. B., Trouw, L. A., Veerhuis, R., Dirven, C. M. F., Lamfers, M. L. M., & Al-Khawaja, H. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.11.016 · Cited by 66
Cancer cells release anaphylatoxin C5a from C5 by serine protease to enhance invasiveness
Nitta, H., Murakami, Y., Wada, Y., Eto, M., Baba, H., & Imamura, T. (2014) · Oncology Reports · doi:10.3892/or.2014.3341 · Cited by 65
Ytting, H., Christensen, I. J., Thiel, S., Jensenius, J. C., & Nielsen, H. J. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1272 · Cited by 63
Regulation of complement-dependent cytotoxicity by TGF-β-induced epithelial–mesenchymal transition
Goswami, M. T., Reka, A. K., Kurapati, H., Kaza, V., Chen, J., Standiford, T. J., & Keshamouni, V. G. (2015) · Oncogene · doi:10.1038/onc.2015.258 · Cited by 62
Zhou, M., Ma, H., Lin, H., & Qin, J. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.10.070 · Cited by 62
Abdelbaset‐Ismail, A., Borkowska-Rzeszotek, S., Kubiś, E., Bujko, K., Brzeźniakiewicz‐Janus, K., Bołkuń, Ł., Kloczko, J. S., Moniuszko, M., Basak, G. W., Wiktor-Jędrzejczak, W., et al. (2016) · Leukemia · doi:10.1038/leu.2016.198 · Cited by 59
Cao, Q., McIsaac, S. M., & Stadnyk, A. W. (2012) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00213.2011 · Cited by 49
Complement activation product C4d in oral and oropharyngeal squamous cell carcinoma
Ajona, D., Pajares, M. J., Chiara, M., Rodrigo, J. P., Lewintre, E. J., Camps, C., Suarez, C. M., Sebastián, J. V. B., Montuenga, L. M., & Pı́o, R. (2015) · Oral Diseases · doi:10.1111/odi.12363 · Cited by 44
Complement component 3 is a prognostic factor of non-small cell lung cancer
Lin, K., He, S., HE, L., CHEN, J., Cheng, X., Zhang, G., & Zhu, B. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2230 · Cited by 43
Graft-derived complement as a mediator of transplant injury
Zhou, W., Medof, M. E., Heeger, P. S., & Sacks, S. H. (2007) · Current Opinion in Immunology · doi:10.1016/j.coi.2007.07.007 · Cited by 40
Complement cascade gene expression defines novel prognostic subgroups of acute myeloid leukemia
Laverdière, I., Boileau, M., Herold, T., Rak, J. W., Berdel, W. E., Wormann, B. J., Hiddemann, W., Spiekermann, K., Bohlander, S. K., & Eppert, K. (2016) · Experimental Hematology · doi:10.1016/j.exphem.2016.07.012 · Cited by 34
A1BG and C3 are overexpressed in patients with cervical intraepithelial neoplasia III
CANALES, N. A. G., Marina, V. M., Salmerón, J., Antúnez, A., Mendoza‐Hernández, G., Langley, E., Román, M. B., & Romero, J. I. C. (2014) · Oncology Letters · doi:10.3892/ol.2014.2195 · Cited by 26
Wan, J., Zhou, X., Cui, J., Zou, Z., Xu, Y., & You, D. (2012) · Molecular Biotechnology · doi:10.1007/s12033-012-9547-2 · Cited by 25
Identification of a 35 kD tumor-associated autoantigen in papillary thyroid carcinoma.
Lucas, S., Ek, B., Rask, L., Rastad, J., Åkerström, G., & Juhlin, C. (1996) · PubMed · Cited by 6
Cited by
Su, S., Chen, J., Yao, H., Liu, J., Yu, S., Lao, L., Wang, M., Luo, M., Xing, Y., Chen, F., et al. (2018) · Cell · doi:10.1016/j.cell.2018.01.009 · Cited by 1,230
The fungal mycobiome promotes pancreatic oncogenesis via activation of MBL
Aykut, B., Pushalkar, S., Chen, R., Li, Q., Abengozar, R., Kim, J. I., Shadaloey, S. A., Wu, D., Preiss, P., Verma, N., et al. (2019) · Nature · doi:10.1038/s41586-019-1608-2 · Cited by 883
Cancer-associated fibroblasts in the single-cell era
Lavie, D., Ben-Shmuel, A., Erez, N., & Scherz-Shouval, R. (2022) · Nature Cancer · doi:10.1038/s43018-022-00411-z · Cited by 616
Chen, F., Chandrashekar, D. S., Varambally, S., & Creighton, C. J. (2019) · Nature Communications · doi:10.1038/s41467-019-13528-0 · Cited by 529
Stealth Coating of Nanoparticles in Drug-Delivery Systems
Fam, S. Y., Chee, C. F., Yong, C. Y., Ho, K. L., Mariatulqabtiah, A. R., & Tan, W. S. (2020) · Nanomaterials · doi:10.3390/nano10040787 · Cited by 422
Metadata
- Authors
- Afshar-Kharghan, V.
- Venue
- Journal of Clinical Investigation
- Published
- 2017-03-01
- Volume
- 127
- Issue
- 3
- Pages
- 780-789
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- OpenAlex
- W2593881435
- Cited by
- 554
- References
- 93
- FWCI
- 14.02
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.